Back to 
Grantham, Mayo, Van Otterloo & Co. LLC
Grantham, Mayo, Van Otterloo & Co. LLC
AMRX
Showing 0 of 10 quarters
Position history for Grantham, Mayo, Van Otterloo & Co. LLC's holdings in Amneal Pharmaceuticals, Inc.
No. Grantham, Mayo, Van Otterloo exited its AMRX (Amneal Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 23,100 shares worth $71,610. Grantham, Mayo, Van Otterloo first reported AMRX in Q3 2020 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.